Epithelial ovarian cancer is usually diagnosed at an advanced stage wi
th a bulky tumor in the pelvis and upper abdomen. The most common ther
apeutic strategy begins by a surgical operation that allows histologic
diagnosis, accurate staging and maximal debulking. Since the papers b
y Griffiths at the end of the seventies, the volume of the residual tu
mor after surgery appears to be one of the most important prognostic f
actors in all series. Indeed, patients whose tumor is completely or op
timally debulked have greater chances of prolonged survival of about 5
0% at 5 years. Surgeons experienced in this field can achieve optimal
debulking in about 75 to 80% of cases. But, in order to reach this obj
ective, they must often perform an ultraradical operation with extensi
ve peritonectomies, lymphadenectomies and intestinal resections. Moreo
ver, since 1983, Hacker has shown that the initial tumor bulk was stil
l a poor prognostic factor even after debulking. Today it can be demon
strated that the greater the tumor bulk the more aggressive must be th
e surgical procedure in order to be optimal and the final benefit will
nevertheless be proportionally lower with a higher morbidity rate. Th
is paradigm leads the surgeons to currently try to more accurately ass
ess the initial tumor bulk in order to determine wether the tumor woul
d be optimally debulked by means of a well-standardised operation. If
not, the alternative strategy would be 3 chemotherapy courses as front
-line treatment before debulking surgery, which hopefully would be eas
ier. Trials are needed in order to validate this strategy despite the
fact that some patients will unfortunately have their prognosis jeopar
dized by the chemoresistance of their tumor.